DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Total Non-Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Assets | ₹6,840 Cr | ₹5,785 Cr | ₹5,113 Cr | ₹5,009 Cr | ₹4,596 Cr |
What is the latest Total Non-Current Assets ratio of DIVIS LABORATORIES ?
| Year | Total Non-Current Assets |
|---|---|
| Mar2025 | ₹6,840 Cr |
| Mar2024 | ₹5,785 Cr |
| Mar2023 | ₹5,113 Cr |
| Mar2022 | ₹5,009 Cr |
| Mar2021 | ₹4,596 Cr |
How is Total Non-Current Assets of DIVIS LABORATORIES Trending?
| Years | Total Non-Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹6,840 Cr | 18.24 | |
| Mar2024 | ₹5,785 Cr | 13.14 | |
| Mar2023 | ₹5,113 Cr | 2.08 | |
| Mar2022 | ₹5,009 Cr | 8.97 | |
| Mar2021 | ₹4,596 Cr | - | |
Compare Total Non-Current Assets of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹163,382.1 Cr | 0.9% | -3% | 0.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹407,827.0 Cr | -0.4% | -0.1% | -2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,193.0 Cr | 2% | 1.7% | 25.2% | Stock Analytics | |
| CIPLA | ₹109,519.0 Cr | -0.9% | -7.2% | -9.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,940.0 Cr | -0.6% | 6.8% | 2.7% | Stock Analytics | |
| MANKIND PHARMA | ₹85,946.0 Cr | -1.1% | -8.2% | -17.5% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | 0.9% |
-3% |
0.8% |
| SENSEX | -0.9% |
-0.1% |
7% |
You may also like the below Video Courses